Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

McLaren Health Care Awards President’s Trophy to Karmanos Cancer Institute

McLaren Health Care has presented its annual President’s Trophy to Karmanos Cancer Institute, recognizing the Detroit-based, nationally renowned c...

Read More

Karmanos, WSU Faculty Members Selected by Michigan Cancer Consortium to Support Statewide Cancer Control Efforts

The Michigan Cancer Consortium (MCC) has selected two Barbara Ann Karmanos Cancer Institute researchers and Wayne State University School of Medic...

Read More

IN THE NEWS: Cervical Cancer Awareness Month

94.7 WCSX Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and member of the  Gynecologic Oncology Multidisciplinary Team  at Karmano...

Read More
News

94.7 WCSX | Cervical Cancer Awareness Month

Listen Now

WSGW | Risks of Pancreatic Cancer

Listen Now

WWJ | Karmanos Psychologist on Emotional Impact of Breast Cancer Diagnosis

Listen Now